期刊文献+

应用不同剂量甘露醇治疗老年急性大面积脑梗死临床观察 被引量:9

Clinical observation on different dosages of mannitol in the treatment of elderly patients with acute large area cerebral infarction
下载PDF
导出
摘要 目的研究应用不同剂量甘露醇治疗老年急性大面积脑梗死的疗效及不良反应。方法选择114例经颅脑CT或MRI确诊的老年脑梗死患者,梗死面积>3cm2,随机分为小剂量组和大剂量组,分别给予不同剂量甘露醇治疗,比较2组临床疗效及安全性。结果小剂量组和大剂量组患者总有效率分别为60.3%、60.7%,2组相比差异无统计学意义(P>0.05)。小剂量组相关并发症少于大剂量组,2组相比差异有统计学意义(P<0.05)。结论使用小剂量甘露醇在保证治疗效果情况下,能明显减少电解质紊乱及脑水肿加重等不良反应,值得临床推广。 Objective To study the efficacy of adverse reaction of different dosages of mannitol in the treatment of elderly patients with acute large area cerebral infarction occurred. Methods Totally 114 elderly patients with cerebral infarction diagnosed by craniocerebral CT or MRI were selected, and the infarction area was greater than 3 cm2. They were randomly divided into low dose group and high dose group, and were given different dosages of mannitol, respectively. The clinical efficacy and safety in patients of the two groups were compared. Results The efficacy of low dose group and high dose group after treat- ment was 60.3% and 60.7~, respectively, there was no significant difference (P^0.05). The complications of the low dose group were fewer than the large dose group, both of them were compared, the difference was statistically significant (P〈0.05). Conclusion Small dosages of mannitol in the treatment of acute large area cerebral infarction, can significantly reduce the electrolyte disorder and brain edema aggravated, it is worthy of clinical promotion.
作者 侯士云
出处 《中国实用神经疾病杂志》 2013年第19期33-34,共2页 Chinese Journal of Practical Nervous Diseases
关键词 甘露醇 脑梗死 不良反应 Mannitol Cerebral infarction Adverse reaction
  • 相关文献

参考文献7

  • 1Simard JM, Sahuquillo J, Sheth KN, et al. Managing malig nant cerebral infarction[J]. Curt Treat Options Neurol, 2011, 13(2) :217-229.
  • 2黄楚泉,张圳锐,吴少波.脑梗死与血浆同型半胱氨酸水平及颈动脉粥样硬化的相关性研究[J].中国实用神经疾病杂志,2012,15(19):3-6. 被引量:28
  • 3Chen KB, Wei VC, Yen LF, et al. Intravenous mannitol does not increase blood-brain barrier permeability to inert dyes in the adult rat forebrain[J]. Neuroreport, 2013,24(6)303- 307.
  • 4Sun YY, Yang D, Kuan CY. Mannitol facilitated perfusion staining with 2,3, 5 triphenyltetrazolium chloride (TTC) fordetection of experimental cerebral infarction and biochemical a nalysis[J]. J NeurosciMethods, 2012, 203(1) :122-129.
  • 5Diringer MN, Scalfani MT, Zazulia AR, et al. Cerebral hemo dynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ische mic stroke [J]. Neurocrit Care, 2011,14(1):11-17.
  • 6Helbok R, Kurtz P, Schmidt JM,et al. Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke [J]. J Neurol Neurosurg Psychiatry,2011,82(4) :378- 383.
  • 7Diringer MN, Scalfani MT, Zazulia AR, et al. Cerebral hemo dynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ische- micstroke [J]. Neurocrit Care,2011,14(1)11-17.

二级参考文献13

  • 1易兴阳,陈存木,池丽芬,黄毅,张顺开.颈动脉粥样硬化与进展性缺血性脑卒中的关系[J].中华神经科杂志,2006,39(6):388-391. 被引量:101
  • 2王桂红,王拥军,何耀,姜卫剑,杜彬,金旻.血浆同型半胱氨酸水平与脑大动脉粥样硬化性病变的相关性分析[J].中华内科杂志,2006,45(9):744-747. 被引量:30
  • 3吴建峰.动脉粥样硬化性脑梗死患者血浆高同型半胱氨酸水平分析[J].交通医学,2006,20(5):533-533. 被引量:2
  • 4吴江.神经病学[M].2版.北京:人民卫生出版社,2010:8.
  • 5Shoenfeld Y, Sherer Y, Harats D, et al. Atherosclerosis as an infectious, inflammatory and autoimmune disease[J].Trends in Immunology, 2001, 22(6); 293 295.
  • 6Atsushi Hoshino, Takashi Nakamura. Prevalence of coronary artery disease in Japanese patients with cerebral infarction im- pact of metabolic syndrome and intraeranial large artery athero- sclerosis[J]. Circulation Journal, 2008, 72(3); 404-408.
  • 7Jane Durga, Petra Verhoef, Mchiel L,et al. Homocysteine and carotid intima-media thickness: a critical appraisal of the evi- deneeEJJ. Atherosclerosis, 2004, 176(1) : 1 19.
  • 8Hoshino A, Nakamura T, Enomoto S, et al, Prevalence of coronary artery disease in Japanese patients with cerebral in- farction impact of metabolic syndrome and intracraniallarge ar- teryatherosclerosis[J].CircJ, 2008, 72(3): 404-408.
  • 9Choy PC, Mymin D, Zhu Q, et al. Atherosclerosis risk fac- tors: the possible role of homocysteine[J].Molecular and Cel- lular Biochemistry, 2000, 207(1/2): 143-148.
  • 10Woo KS, Chook P, Lolin YI, et al. Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans[J]. Circulation, 1997, 96:25 421.

共引文献27

同被引文献72

引证文献9

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部